Back to top
more

AdaptHealth (AHCO)

(Delayed Data from NSDQ)

$9.78 USD

9.78
522,986

-0.03 (-0.31%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $9.78 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (152 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

AHCO vs. BSX: Which Stock Is the Better Value Option?

AHCO vs. BSX: Which Stock Is the Better Value Option?

Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?

Here is how AdaptHealth Corp. (AHCO) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

AHCO or BSX: Which Is the Better Value Stock Right Now?

AHCO vs. BSX: Which Stock Is the Better Value Option?

Philips (PHG) Boosts Patient Monitoring With smartQare Deal

Philips (PHG) partners with smartQare to integrate the latter's viQtor solution, boosting its patient monitoring solutions portfolio.

Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?

Here is how AdaptHealth Corp. (AHCO) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.

AHCO vs. BSX: Which Stock Is the Better Value Option?

AHCO vs. BSX: Which Stock Is the Better Value Option?

Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?

Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.

AHCO vs. HLN: Which Stock Should Value Investors Buy Now?

AHCO vs. HLN: Which Stock Is the Better Value Option?

Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?

Here is how AdaptHealth Corp. (AHCO) and Ascendis Pharma A/S (ASND) have performed compared to their sector so far this year.

Do Options Traders Know Something About AdaptHealth (AHCO) Stock We Don't?

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.

AdaptHealth Corp. (AHCO) Q2 Earnings and Revenues Top Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of 45.45% and 3.60%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates

TG Therapeutics (TGTX) delivered earnings and revenue surprises of -30.77% and 15.75%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Soars 19.6%: Is Further Upside Left in the Stock?

AdaptHealth Corp. (AHCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Are Options Traders Betting on a Big Move in AdaptHealth (AHCO) Stock?

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.

Implied Volatility Surging for AdaptHealth (AHCO) Stock Options

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.

Humana (HUM) Teams Up With DME Entities to Boost Home Solutions

These partnerships will equip Humana (HUM) with the means to deploy advanced clinical programs that can reduce hospitalizations for the members.

AdaptHealth Corp. (AHCO) Q1 Earnings and Revenues Lag Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -87.50% and 2.03%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Implied Volatility Surging for AdaptHealth (AHCO) Stock Options

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.

AdaptHealth Corp. (AHCO) Lags Q4 Earnings and Revenue Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -96.77% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

LeMaitre Vascular (LMAT) Q4 Earnings and Revenues Lag Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -3.85% and 0.57%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Reports Next Week: Wall Street Expects Earnings Growth

AdaptHealth Corp. (AHCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Implied Volatility Surging for AdaptHealth (AHCO) Stock Options

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.

AdaptHealth Corp. (AHCO) Misses Q3 Earnings Estimates

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -64.52% and 2.43%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Stock Jumps 5.2%: Will It Continue to Soar?

AdaptHealth Corp. (AHCO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Implied Volatility Surging for AdaptHealth (AHCO) Stock Options

Investors need to pay close attention to AdaptHealth (AHCO) stock based on the movements in the options market lately.